FDA Changes to the CAR-T Monitoring Program
Update: 2025-08-31
Description
Dr. Saurabh Dahiya from Stanford University explains the recent changes in the FDA recommendations regarding the monitoring program previously mandated for centers delivering CAR-T therapies, and why this decision was celebrated by patients and their physicians.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
